𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMAB

✍ Scribed by P. Anaya; F. Aldaco

Book ID
119309670
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
60 KB
Volume
14
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PCN9 VALIDITY OF PROPORTIONAL HAZARDS (P
PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ (HER2+) METASTATIC BREAST CANCER (MBC) RECEIVING LAPATINIB PLUS CAPECITABINE (L+C) VERSUS CAPECITABINE ONLY (C-ONLY)
✍ O Sofrygin; T Delea; P Tappenden; J Karnon; MM Amonkar; M Walker πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 69 KB